No abstract

Background: Pre-exposure prophylaxis (PrEP), the usage of antiretroviral medications in HIV-uninfected individuals to prevent acquisition of HIV, has been identified to be sufficient and safe for HIV prevention. Case presentation: A surgeon was prescribed Tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) as pre-exposure prophylaxis before he performed a surgery for HIV positive patient. After occupational exposure, he was prescribed TDF/FTC and Raltegravir as postexposure prophylaxis. Serology confirmed no HIV infection at follow-ups. Conclusion: This brief report presents a case who received PrEP and PEP in an occupational exposure to indicate the feasibility of the use of PrEP in occupational exposure.